MULTICENTER DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL OF THE SYMPTOM-  AND STRUCTURE-MODIFYING EFFECT OF ALFLUTOP IN PATIENTS WITH KNEE OSTEOARTHROSIS.  COMMUNICATION 1. EVALUATION OF THE SYMPTOM-MODIFYING EFFECT OF THE DRUG

Lyudmila Ivanovna Alekseeva; E P Sharapova; E A Taskina; N V Chichasova; G R Imametdinova; N A Shostak; N G Pravdyuk; L N Denisov

For citations:

Alekseeva L.I., Sharapova E.P., Taskina E.A., Chichasova N.V., Imametdinova G.R., Shostak N.A., Pravdyuk N.G., Denisov L.N. MULTICENTER DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL OF THE SYMPTOM- AND STRUCTURE-MODIFYING EFFECT OF ALFLUTOP IN PATIENTS WITH KNEE OSTEOARTHROSIS. COMMUNICATION 1. EVALUATION OF THE SYMPTOM-MODIFYING EFFECT OF THE DRUG. Rheumatology Science and Practice. 2013;51(5):532-538. (In Russ.) https://doi.org/10.14412/1995-4484-2013-1545

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Rheumatology Science and Practice

For citations:

Cookies policy